[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"human-papillomavirus-related-malignant-neoplasm\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:human-papillomavirus-related-malignant-neoplasm":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100647308","a-scientific-evaluation-of-one-or-two-doses-of-a-vaccine-against-human-papillomavirus-long-term-follow-up-of-gardasil9-recipients-in-the-escuddo-study-estudio-de-comparacin-de-una-y-dos-dosis-de-vacunas-contra-el-virus-de-papiloma-humano-vph-100647308",false,"NCT07706673","ESCUDDO Long Term Follow Up","A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study (\"Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano (VPH)\")","ESCUDDO LTFU","Inclusion Criteria:\n\n* \\* Participation in ESCUDDO base study\n\n  * Randomization (excluding the two participants who had major protocol deviations in the ESCUDDO base study) to the Gardasil9 1- and 2-dose arms\n  * A signed informed consent form for ESCUDDO LTFU.\n  * Opportunity to complete three total study visits\n  * LTFU Survey group:\n\n    * We will match the current ages of ESCUDDO LTFU trial participants when they attend their 9.5-year study visit (21 to 26 years of age)\n\nExclusion Criteria:\n\n* \\* Enrollment cannot occur beyond her 10 year study visit\n\n  * LTFU Survey group:\n\n    * They report they are pregnant;\n    * They report being vaccinated against HPV;\n    * The qualified healthcare personnel determining eligibility, in agreement with principal investigator, considers a reason that precludes participation; or\n    * They do not have an identification document",true,"FEMALE","18 Years",{"count":21,"type":22},9700,"ESTIMATED","OBSERVATIONAL","This study evaluates the long term protection provided by either one or two doses of the 9vHPV vaccine for participants who were part of the ESCUDDO study.",[26,27],"Human Papillomavirus Infection","Human Papillomavirus-Related Malignant Neoplasm","NOT_YET_RECRUITING","2026-08-19",{"date":31,"type":32},"2026-08-20","ACTUAL",{"date":34,"type":22},"2026-09-17",{"date":36,"type":22},"2031-01-15",{"name":38,"class":39},"National Cancer Institute (NCI)","NIH"]